真实世界数据评估度普利尤单抗的有效性、安全性和药物存续性：德国 TREAT 注册研究分析。
Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry.
机构信息
Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
出版信息
Br J Dermatol. 2022 Dec;187(6):1022-1024. doi: 10.1111/bjd.21794. Epub 2022 Sep 6.
PMID:35895855
Abstract
This interim analysis from the atopic dermatitis registry TREATgermany shows robust long-term efficacy, favourable safety and high persistence of dupilumab under real life conditions.
摘要
该特应性皮炎登记研究 TREATgermany 的这一中期分析显示，度普利尤单抗在真实环境下具有强劲的长期疗效、良好的安全性和高持久性。
Zotero 插件